ENOX2 and cancer: Inhibition of tNOX expression/activity has been recently reported to affect mitochondrial function by decreasing NAD+-dependent SIRT1 deacetylase activity and increasing acetylation of p53, which causes augmentation of ROS-dependent mitochondrial autophagia and induces apoptosis in cancer cells [103,104,105,106].